US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

46.35

-0.5900-1.26%

Post-market: 46.350.00000.00%18:10 EDT

Volume:2.71M

Turnover:126.39M

Market Cap:27.03B

PE:26.02

High:47.33

Open:47.00

Low:46.06

Close:46.94

52wk High:47.86

52wk Low:29.66

Shares:583.17M

Float Shares:379.85M

Volume Ratio:0.64

T/O Rate:0.71%

Dividend:0.88

Dividend Rate:1.90%

EPS(TTM):1.78

EPS(LYR):1.78

ROE:13.20%

ROA:5.15%

PB:4.17

PE(LYR):26.02

Loading ...

Overview Company News Filings

Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares

Royalty Pharma provides update on business performance

Royalty Pharma Targets 14%-16% Top-Line Growth for 2025

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44TH Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS

Royalty Pharma, Teva enter agreement to accelerate development of TEV-‘408

BRIEF-Teva And Royalty Pharma Enter Agreement To Accelerate Development Of Potential Treatment For Vitiligo

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

THOMSON REUTERS

Teva - Teva to Share Tev-'408 Trial Results in 2026

THOMSON REUTERS

Royalty Pharma - to Provide up to $500 Mln for Teva's Tev-'408

THOMSON REUTERS

Royalty Pharma : Tev-'408 Is Currently in Phase 1B for Treatment of Vitiligo and in Phase 2a for Celiac Disease

THOMSON REUTERS

Teva and Royalty Pharma Partner in $500 Million Deal to Advance TEV-'408 for Vitiligo

Assessing Royalty Pharma (RPRX) Valuation After Dividend Increase And Raised Full Year Guidance

Simply Wall St.

Royalty Pharma Increases Quarterly Dividend to $0.235 a Share From $0.22, Payable March 10 to Holders of Record on Feb. 20.

MT Newswires Live

Royalty Pharma announces $0.235 quarterly dividend

Royalty Pharma : Dividend of $0.235 per Share Reflects 6.8% Increase in Company's Quarterly Dividend

THOMSON REUTERS

Royalty Pharma - Declares Dividend of $0.235 per Share

THOMSON REUTERS

Royalty Pharma Files Initial Beneficial Ownership Statement for Arthur Richard McGivern, EVP, Investments & General Counsel

Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares

Denali Therapeutics reports $872.9 million cash position ahead of key 2026 milestones

What's Going On With Royalty Pharma Stock Wednesday?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RPRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","market":"US","secType":"STK","nameCN":"Royalty Pharma plc","latestPrice":46.35,"timestamp":1774641600000,"preClose":46.94,"halted":0,"volume":2710159,"hourTrading":{"tag":"盘后","latestPrice":46.35,"preClose":46.35,"latestTime":"18:10 EDT","volume":76495,"amount":3549717.658,"timestamp":1774649412896,"change":0,"changeRate":0,"amplitude":0.00589},"delay":0,"changeRate":-0.012569237324243638,"floatShares":379849980,"shares":583174298,"eps":1.781403,"marketStatus":"Market Closed","change":-0.59,"latestTime":"03-27 16:00:00 EDT","open":46.995,"high":47.33,"low":46.06,"amount":126388218.892297,"amplitude":0.027056,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.781403,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1592280000000,"exchange":"NASDAQ","adjPreClose":46.94,"dividendRate":0.018986,"preHourTrading":{"tag":"盘前","latestPrice":47.26,"preClose":46.94,"latestTime":"09:20 EDT","volume":7472,"amount":350385.9904,"timestamp":1774617611010,"change":0.32,"changeRate":0.006817,"amplitude":0.01553},"postHourTrading":{"tag":"盘后","latestPrice":46.35,"preClose":46.35,"latestTime":"18:10 EDT","volume":76495,"amount":3549717.658,"timestamp":1774649412896,"change":0,"changeRate":0,"amplitude":0.00589},"volumeRatio":0.640336,"impliedVol":0.3079,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","floatShares":379849980,"roa":"5.15%","roe":"13.20%","lyrEps":1.781403,"volumeRatio":0.640336,"shares":583174298,"dividePrice":0.88,"high":47.33,"amplitude":0.027056,"preClose":46.94,"low":46.06,"week52Low":29.66,"pbRate":"4.17","psRate":"11.37","week52High":47.86,"institutionHeld":0.9297,"latestPrice":46.35,"eps":1.781403,"divideRate":0.018986,"volume":2710159,"delay":0,"ttmEps":1.781403,"open":46.995,"prevYearClose":38.64,"prevWeekClose":45.36,"prevMonthClose":46.21,"prevQuarterClose":38.64,"fiveDayClose":45.36,"twentyDayClose":46.21,"sixtyDayClose":38.99,"dividendPayoutRate":0.4905978045748245,"dividendFrequency":"Q","dividendGrowthYears":5,"dividendGrowthRate":0.047619047619047665,"fiveYearAvgDividendRate":0.02408439366820899},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RPRX\",params:#limit:5,,,undefined,":[{"date":"2026-02-20","symbol":"RPRX","amount":0.235,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-10","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-03-10"},{"market":"US","date":"2026-02-11","symbol":"RPRX","fiscalQuarterEnding":"2025/12","expectedEps":1.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"pre","actualEps":1.46},{"date":"2025-11-14","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-14","defaultRemindTime":1763130600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-10","payableDate":"2025-11-14","currency":"USD","dateTimestamp":1763096400000,"payDate":"2025-12-10"},{"market":"US","date":"2025-11-05","symbol":"RPRX","fiscalQuarterEnding":"2025/09","expectedEps":1.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":1.17},{"date":"2025-08-15","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-10","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-09-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RPRX\",market:\"US\",,,undefined,":[{"executeDate":"2020-09-14","recordDate":"2020-09-15","paymentDate":"2020-09-30","value":0.15,"currency":"USD"},{"executeDate":"2020-11-19","recordDate":"2020-11-20","paymentDate":"2020-12-15","value":0.15,"currency":"USD"},{"executeDate":"2021-02-18","recordDate":"2021-02-19","paymentDate":"2021-03-15","value":0.17,"currency":"USD"},{"executeDate":"2021-05-19","recordDate":"2021-05-20","paymentDate":"2021-06-15","value":0.17,"currency":"USD"},{"executeDate":"2021-08-19","recordDate":"2021-08-20","paymentDate":"2021-09-15","value":0.17,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RPRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1770868800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RPRX","date":"2026-03-27","current":26.018818,"percent":0.500407,"low":9.420627,"twenty":15.379534,"median":26.077607,"eighty":56.189678,"high":536.452748,"avg":54.528835,"sd":101.407359,"marketCap":20109969647},"quantilePoints":[{"date":"2021-04-01","current":26.780274,"twenty":10.841764,"median":12.736219,"eighty":14.558244,"marketCap":26111838518},{"date":"2021-04-09","current":26.344418,"twenty":10.870271,"median":12.777628,"eighty":14.859728,"marketCap":25686860909},{"date":"2021-04-16","current":26.070451,"twenty":10.877008,"median":12.890883,"eighty":15.364506,"marketCap":25419732126},{"date":"2021-04-23","current":27.153866,"twenty":10.880637,"median":12.943264,"eighty":25.867466,"marketCap":26476105040},{"date":"2021-04-30","current":27.609843,"twenty":10.889966,"median":13.040871,"eighty":26.105319,"marketCap":26920701720},{"date":"2021-05-07","current":25.708529,"twenty":10.902405,"median":13.112851,"eighty":26.233724,"marketCap":25066844306},{"date":"2021-05-14","current":25.415982,"twenty":10.923137,"median":13.188745,"eighty":26.203698,"marketCap":24727692206},{"date":"2021-05-21","current":25.397262,"twenty":11.006583,"median":13.242152,"eighty":26.105319,"marketCap":24709478831},{"date":"2021-05-28","current":25.035336,"twenty":11.014357,"median":13.396752,"eighty":26.063326,"marketCap":24357353580},{"date":"2021-06-04","current":28.211553,"twenty":11.037163,"median":13.462808,"eighty":26.226114,"marketCap":27447556215},{"date":"2021-06-11","current":28.01811,"twenty":11.073444,"median":13.525947,"eighty":26.468948,"marketCap":27259351339},{"date":"2021-06-18","current":27.46898,"twenty":11.088992,"median":13.552567,"eighty":26.637064,"marketCap":26725092338},{"date":"2021-06-25","current":26.570403,"twenty":11.125544,"median":13.593515,"eighty":26.668197,"marketCap":25850850335},{"date":"2021-07-02","current":26.35824,"twenty":11.210793,"median":13.670814,"eighty":26.643499,"marketCap":25644432084},{"date":"2021-07-09","current":26.064954,"twenty":11.239817,"median":13.722576,"eighty":26.638351,"marketCap":25359089208},{"date":"2021-07-16","current":26.726929,"twenty":11.289271,"median":13.759358,"eighty":26.648439,"marketCap":26003137199},{"date":"2021-07-23","current":26.581925,"twenty":11.338048,"median":13.881632,"eighty":26.679943,"marketCap":25862059759},{"date":"2021-07-30","current":25.17802,"twenty":11.350107,"median":13.916375,"eighty":26.648439,"marketCap":24496173638},{"date":"2021-08-06","current":24.380496,"twenty":11.371465,"median":14.057313,"eighty":26.638351,"marketCap":23720247719},{"date":"2021-08-13","current":24.202628,"twenty":11.413966,"median":14.101803,"eighty":26.627102,"marketCap":23515781358},{"date":"2021-08-20","current":24.371352,"twenty":11.425707,"median":14.162722,"eighty":26.606281,"marketCap":23679717867},{"date":"2021-08-27","current":24.490085,"twenty":11.428044,"median":14.303845,"eighty":26.590141,"marketCap":23795080595},{"date":"2021-09-03","current":24.565073,"twenty":11.442485,"median":14.393216,"eighty":26.58299,"marketCap":23867941265},{"date":"2021-09-10","current":24.046401,"twenty":11.483683,"median":14.412385,"eighty":26.575012,"marketCap":23363988295},{"date":"2021-09-17","current":24.058899,"twenty":11.513281,"median":14.476137,"eighty":26.520738,"marketCap":23376131740},{"date":"2021-09-24","current":23.18403,"twenty":11.53978,"median":14.588573,"eighty":26.47642,"marketCap":22526090586},{"date":"2021-10-01","current":22.640362,"twenty":11.560125,"median":14.847176,"eighty":26.437867,"marketCap":21997850726},{"date":"2021-10-08","current":22.177931,"twenty":11.592778,"median":15.062517,"eighty":26.384717,"marketCap":21548543258},{"date":"2021-10-15","current":23.99016,"twenty":11.640462,"median":15.413014,"eighty":26.360183,"marketCap":23309342792},{"date":"2021-10-22","current":23.433993,"twenty":11.659417,"median":22.124814,"eighty":26.350751,"marketCap":22768959487},{"date":"2021-10-29","current":24.702553,"twenty":11.679854,"median":22.271667,"eighty":26.344954,"marketCap":24001519161},{"date":"2021-11-05","current":24.696304,"twenty":11.723704,"median":22.559124,"eighty":26.333991,"marketCap":23995447438},{"date":"2021-11-12","current":32.51009,"twenty":11.752375,"median":22.640362,"eighty":26.350751,"marketCap":25452734666},{"date":"2021-11-19","current":32.2309,"twenty":11.763977,"median":22.8872,"eighty":26.47642,"marketCap":25234152021},{"date":"2021-11-26","current":32.486824,"twenty":11.775219,"median":22.924694,"eighty":26.585121,"marketCap":25434519446},{"date":"2021-12-03","current":29.19859,"twenty":11.807468,"median":23.015305,"eighty":26.640925,"marketCap":22860101627},{"date":"2021-12-10","current":29.291653,"twenty":11.847383,"median":23.171532,"eighty":26.80037,"marketCap":22932962508},{"date":"2021-12-17","current":29.888809,"twenty":11.870433,"median":23.215276,"eighty":26.895847,"marketCap":23400486499},{"date":"2021-12-23","current":31.21496,"twenty":11.891419,"median":23.371502,"eighty":27.107873,"marketCap":24438754063},{"date":"2021-12-31","current":30.904749,"twenty":11.910529,"median":23.48711,"eighty":27.173363,"marketCap":24195884457},{"date":"2022-01-07","current":31.222715,"twenty":11.93171,"median":23.58397,"eighty":27.251023,"marketCap":24444825803},{"date":"2022-01-14","current":30.757399,"twenty":11.982869,"median":23.843307,"eighty":27.501351,"marketCap":24080521395},{"date":"2022-01-21","current":30.354125,"twenty":12.0166,"median":23.915171,"eighty":27.798092,"marketCap":23764790907},{"date":"2022-01-28","current":30.602294,"twenty":12.025032,"median":23.99016,"eighty":27.981993,"marketCap":23959086592},{"date":"2022-02-04","current":30.997812,"twenty":12.078439,"median":24.05265,"eighty":28.604645,"marketCap":24268745339},{"date":"2022-02-11","current":30.912504,"twenty":12.120603,"median":24.152635,"eighty":28.953331,"marketCap":24201956198},{"date":"2022-02-18","current":38.611798,"twenty":12.199308,"median":24.193255,"eighty":29.097649,"marketCap":23928812189},{"date":"2022-02-25","current":37.690836,"twenty":12.300501,"median":24.209173,"eighty":29.140126,"marketCap":23358066605},{"date":"2022-03-04","current":37.641849,"twenty":12.370773,"median":24.296364,"eighty":29.218581,"marketCap":23327707798},{"date":"2022-03-11","current":37.494887,"twenty":12.393263,"median":24.333858,"eighty":29.372308,"marketCap":23236631375},{"date":"2022-03-18","current":38.523621,"twenty":12.400806,"median":24.371352,"eighty":29.55223,"marketCap":23874166335},{"date":"2022-03-25","current":37.592862,"twenty":12.401989,"median":24.41822,"eighty":29.826979,"marketCap":23297348990},{"date":"2022-04-01","current":38.56281,"twenty":12.415244,"median":24.490085,"eighty":30.011342,"marketCap":23898453382},{"date":"2022-04-08","current":40.581088,"twenty":12.46803,"median":24.558469,"eighty":30.160243,"marketCap":25149236257},{"date":"2022-04-14","current":43.206807,"twenty":12.481269,"median":24.62444,"eighty":30.337063,"marketCap":26776468347},{"date":"2022-04-22","current":41.977613,"twenty":12.531575,"median":24.702553,"eighty":30.374674,"marketCap":26014702030},{"date":"2022-04-29","current":41.717726,"twenty":12.617931,"median":24.768168,"eighty":30.481311,"marketCap":25853642688},{"date":"2022-05-06","current":40.037043,"twenty":12.672923,"median":24.835282,"eighty":30.64107,"marketCap":24117113377},{"date":"2022-05-13","current":40.258799,"twenty":12.697537,"median":24.934608,"eighty":30.867524,"marketCap":24250692555},{"date":"2022-05-20","current":39.835446,"twenty":12.713191,"median":25.066536,"eighty":30.997812,"marketCap":23995677761},{"date":"2022-05-27","current":41.599415,"twenty":12.727345,"median":25.116457,"eighty":31.059854,"marketCap":25058239402},{"date":"2022-06-03","current":40.843428,"twenty":12.733261,"median":25.194498,"eighty":31.165326,"marketCap":24602855842},{"date":"2022-06-10","current":40.803109,"twenty":12.735627,"median":25.334861,"eighty":31.219613,"marketCap":24578568718},{"date":"2022-06-17","current":39.664089,"twenty":12.739177,"median":25.403502,"eighty":31.585662,"marketCap":23892457487},{"date":"2022-06-24","current":43.54482,"twenty":12.746867,"median":25.497104,"eighty":32.196777,"marketCap":26230093099},{"date":"2022-07-01","current":43.081148,"twenty":12.778811,"median":25.671953,"eighty":32.432537,"marketCap":25950791181},{"date":"2022-07-08","current":43.302904,"twenty":12.783544,"median":25.758729,"eighty":32.51009,"marketCap":26084370359},{"date":"2022-07-15","current":44.280647,"twenty":12.872277,"median":25.81215,"eighty":32.913364,"marketCap":26673333098},{"date":"2022-07-22","current":43.575059,"twenty":12.909488,"median":25.883655,"eighty":37.112786,"marketCap":26248308441},{"date":"2022-07-29","current":43.837135,"twenty":12.927331,"median":25.924329,"eighty":37.494887,"marketCap":26406174742},{"date":"2022-08-05","current":55.302721,"twenty":12.943264,"median":26.008185,"eighty":37.641849,"marketCap":25776487684},{"date":"2022-08-12","current":57.582574,"twenty":12.984673,"median":26.031171,"eighty":37.739824,"marketCap":26839122629},{"date":"2022-08-19","current":57.452297,"twenty":13.031997,"median":26.064954,"eighty":37.955368,"marketCap":26778400632},{"date":"2022-08-26","current":56.084385,"twenty":13.049744,"median":26.130056,"eighty":38.170912,"marketCap":26140819665},{"date":"2022-09-02","current":54.807667,"twenty":13.070449,"median":26.166685,"eighty":38.396254,"marketCap":25545744095},{"date":"2022-09-09","current":56.839993,"twenty":13.104371,"median":26.235626,"eighty":38.531459,"marketCap":26493007247},{"date":"2022-09-16","current":54.651334,"twenty":13.130841,"median":26.335729,"eighty":38.654091,"marketCap":25472877699},{"date":"2022-09-23","current":52.540842,"twenty":13.157825,"median":26.35824,"eighty":38.942952,"marketCap":24489181349},{"date":"2022-09-30","current":52.345426,"twenty":13.203924,"median":26.443047,"eighty":39.5308,"marketCap":24398098354},{"date":"2022-10-07","current":53.231312,"twenty":13.220789,"median":26.570403,"eighty":39.868964,"marketCap":24811007933},{"date":"2022-10-14","current":53.947837,"twenty":13.238217,"median":26.594475,"eighty":40.109618,"marketCap":25144978916},{"date":"2022-10-21","current":53.439755,"twenty":13.287126,"median":26.637064,"eighty":40.381773,"marketCap":24908163128},{"date":"2022-10-28","current":55.706581,"twenty":13.343344,"median":26.697563,"eighty":40.596976,"marketCap":25964725874},{"date":"2022-11-04","current":54.638307,"twenty":13.42205,"median":26.813768,"eighty":40.835364,"marketCap":25466805499},{"date":"2022-11-11","current":52.620617,"twenty":13.438915,"median":26.87804,"eighty":41.030913,"marketCap":26669181236},{"date":"2022-11-18","current":51.362611,"twenty":13.477144,"median":26.991976,"eighty":41.419994,"marketCap":26031598351},{"date":"2022-11-25","current":51.494402,"twenty":13.508626,"median":27.128959,"eighty":41.588023,"marketCap":26098392749},{"date":"2022-12-02","current":52.53675,"twenty":13.524865,"median":27.163206,"eighty":41.70117,"marketCap":26626675710},{"date":"2022-12-09","current":50.020737,"twenty":13.531271,"median":27.175694,"eighty":42.099572,"marketCap":25351509941},{"date":"2022-12-16","current":48.175661,"twenty":13.536595,"median":27.242334,"eighty":42.522809,"marketCap":24416388376},{"date":"2022-12-23","current":47.253123,"twenty":13.555525,"median":27.46898,"eighty":42.883467,"marketCap":23948827594},{"date":"2022-12-30","current":47.348971,"twenty":13.573322,"median":27.509444,"eighty":43.081148,"marketCap":23997405338},{"date":"2023-01-06","current":45.635686,"twenty":13.58452,"median":27.609843,"eighty":43.15977,"marketCap":23129078171},{"date":"2023-01-13","current":47.169255,"twenty":13.602481,"median":27.828632,"eighty":43.302904,"marketCap":23906322069},{"date":"2023-01-20","current":45.92323,"twenty":13.638343,"median":27.953974,"eighty":43.369326,"marketCap":23274811402},{"date":"2023-01-27","current":46.606148,"twenty":13.663787,"median":28.075391,"eighty":43.492269,"marketCap":23620927825},{"date":"2023-02-03","current":46.678034,"twenty":13.677842,"median":28.635778,"eighty":43.575059,"marketCap":23657361133},{"date":"2023-02-10","current":45.647667,"twenty":13.700329,"median":28.791441,"eighty":44.018571,"marketCap":23135150389},{"date":"2023-02-17","current":536.452748,"twenty":13.744823,"median":28.985327,"eighty":45.527856,"marketCap":22977344089},{"date":"2023-02-24","current":515.754518,"twenty":13.745207,"median":29.047283,"eighty":45.638082,"marketCap":22090797514},{"date":"2023-03-03","current":505.263634,"twenty":13.756547,"median":29.121037,"eighty":45.865721,"marketCap":21641451990},{"date":"2023-03-10","current":469.254386,"twenty":13.824571,"median":29.181811,"eighty":46.294641,"marketCap":20099103841},{"date":"2023-03-17","current":491.086765,"twenty":13.863361,"median":29.214845,"eighty":46.433622,"marketCap":21034228309},{"date":"2023-03-24","current":502.286492,"twenty":13.889221,"median":29.284382,"eighty":46.639695,"marketCap":21513935017},{"date":"2023-03-31","current":510.792614,"twenty":13.89653,"median":29.384716,"eighty":46.953597,"marketCap":21878269226},{"date":"2023-04-06","current":514.195062,"twenty":13.908662,"median":29.389187,"eighty":46.991936,"marketCap":22024002909},{"date":"2023-04-14","current":517.881048,"twenty":13.930103,"median":29.629008,"eighty":47.183633,"marketCap":22181881066},{"date":"2023-04-21","current":511.926763,"twenty":14.003344,"median":29.811522,"eighty":47.38731,"marketCap":21926847120},{"date":"2023-04-28","current":501.012305,"twenty":14.059562,"median":29.901277,"eighty":48.453621,"marketCap":21459359029},{"date":"2023-05-05","current":494.632691,"twenty":14.081953,"median":30.06718,"eighty":50.15732,"marketCap":21186107429},{"date":"2023-05-12","current":63.132216,"twenty":14.097435,"median":30.121467,"eighty":50.607807,"marketCap":20949289375},{"date":"2023-05-19","current":61.532363,"twenty":14.125705,"median":30.273353,"eighty":51.046312,"marketCap":20418037790},{"date":"2023-05-26","current":58.989098,"twenty":14.148386,"median":30.350248,"eighty":51.427308,"marketCap":19574116514},{"date":"2023-06-02","current":60.690707,"twenty":14.160754,"median":30.36188,"eighty":51.544722,"marketCap":20138754490},{"date":"2023-06-09","current":63.179081,"twenty":14.184848,"median":30.416167,"eighty":52.19192,"marketCap":20964461638},{"date":"2023-06-16","current":58.915911,"twenty":14.243506,"median":30.482087,"eighty":52.539205,"marketCap":19549831009},{"date":"2023-06-23","current":56.738584,"twenty":14.315085,"median":30.602294,"eighty":52.629752,"marketCap":18827337255},{"date":"2023-06-29","current":54.158725,"twenty":14.348803,"median":30.610049,"eighty":52.716465,"marketCap":17971273226},{"date":"2023-07-07","current":55.787147,"twenty":14.368253,"median":30.7225,"eighty":53.147934,"marketCap":18511625698},{"date":"2023-07-14","current":56.189678,"twenty":14.385627,"median":30.817667,"eighty":53.439755,"marketCap":18645195972},{"date":"2023-07-21","current":57.031334,"twenty":14.406989,"median":30.912504,"eighty":53.523133,"marketCap":18924479272},{"date":"2023-07-28","current":56.720287,"twenty":14.411846,"median":30.997812,"eighty":53.911359,"marketCap":18821265879},{"date":"2023-08-04","current":55.970115,"twenty":14.415735,"median":31.028834,"eighty":54.260503,"marketCap":18572339459},{"date":"2023-08-11","current":72.162914,"twenty":14.43566,"median":31.102508,"eighty":54.461129,"marketCap":18397718410},{"date":"2023-08-18","current":69.094161,"twenty":14.479538,"median":31.168428,"eighty":54.648729,"marketCap":17615348965},{"date":"2023-08-25","current":69.778729,"twenty":14.509418,"median":31.203327,"eighty":54.763373,"marketCap":17789877534},{"date":"2023-09-01","current":70.392479,"twenty":14.580141,"median":31.269247,"eighty":54.978425,"marketCap":17946351423},{"date":"2023-09-08","current":68.126323,"twenty":14.602628,"median":31.455373,"eighty":55.107305,"marketCap":17368601679},{"date":"2023-09-15","current":67.890265,"twenty":14.667652,"median":31.928445,"eighty":55.289693,"marketCap":17308419414},{"date":"2023-09-22","current":61.988816,"twenty":14.847176,"median":32.246411,"eighty":55.641442,"marketCap":15803862789},{"date":"2023-09-29","current":63.216318,"twenty":14.859728,"median":32.339474,"eighty":55.973774,"marketCap":16116810567},{"date":"2023-10-06","current":62.767808,"twenty":15.016671,"median":32.482946,"eighty":56.080794,"marketCap":16002464263},{"date":"2023-10-13","current":63.971703,"twenty":15.066953,"median":32.556622,"eighty":56.189678,"marketCap":16309393815},{"date":"2023-10-20","current":66.355888,"twenty":15.150362,"median":32.773769,"eighty":56.544637,"marketCap":16917234691},{"date":"2023-10-27","current":64.32579,"twenty":15.218983,"median":32.928874,"eighty":56.599178,"marketCap":16399667212},{"date":"2023-11-03","current":64.868723,"twenty":16.726003,"median":36.907039,"eighty":56.712968,"marketCap":16538086422},{"date":"2023-11-10","current":88.80003,"twenty":21.996708,"median":37.21566,"eighty":56.826842,"marketCap":16375613449},{"date":"2023-11-17","current":85.949098,"twenty":22.092944,"median":37.494887,"eighty":56.889499,"marketCap":15849873215},{"date":"2023-11-24","current":87.765402,"twenty":22.177931,"median":37.592862,"eighty":57.067927,"marketCap":16184817745},{"date":"2023-12-01","current":65.305922,"twenty":22.190429,"median":37.666342,"eighty":57.217798,"marketCap":12043065075},{"date":"2023-12-08","current":69.407144,"twenty":22.271667,"median":37.730026,"eighty":57.452297,"marketCap":12799371342},{"date":"2023-12-15","current":69.069396,"twenty":22.390399,"median":37.75452,"eighty":57.77799,"marketCap":12737087296},{"date":"2023-12-22","current":66.053792,"twenty":22.540377,"median":37.955368,"eighty":58.915911,"marketCap":12180979747},{"date":"2023-12-29","current":67.453032,"twenty":22.562873,"median":37.997597,"eighty":59.09156,"marketCap":12439013650},{"date":"2024-01-05","current":67.067035,"twenty":22.579121,"median":38.02395,"eighty":59.439201,"marketCap":12367831884},{"date":"2024-01-12","current":69.021146,"twenty":22.595368,"median":38.190507,"eighty":60.273538,"marketCap":12728189575},{"date":"2024-01-19","current":67.646031,"twenty":22.640362,"median":38.303178,"eighty":60.799389,"marketCap":12474604533},{"date":"2024-01-26","current":70.227388,"twenty":22.677856,"median":38.50491,"eighty":61.532363,"marketCap":12950632595},{"date":"2024-02-02","current":69.19002,"twenty":22.884075,"median":38.587304,"eighty":61.916597,"marketCap":12759331598},{"date":"2024-02-09","current":69.23827,"twenty":22.890324,"median":38.625868,"eighty":62.198957,"marketCap":12768229319},{"date":"2024-02-16","current":11.82036,"twenty":22.884075,"median":38.696427,"eighty":62.821129,"marketCap":13414146195},{"date":"2024-02-23","current":12.210042,"twenty":22.58287,"median":38.613793,"eighty":62.778472,"marketCap":13856370795},{"date":"2024-03-01","current":11.942381,"twenty":22.255419,"median":38.523621,"eighty":62.312727,"marketCap":13552620565},{"date":"2024-03-08","current":11.824296,"twenty":20.664972,"median":38.430545,"eighty":62.163037,"marketCap":13418613110},{"date":"2024-03-15","current":11.749508,"twenty":15.016671,"median":38.210102,"eighty":62.021864,"marketCap":13333741722},{"date":"2024-03-22","current":11.977807,"twenty":14.597006,"median":38.097431,"eighty":61.966617,"marketCap":13592822801},{"date":"2024-03-28","current":11.98568,"twenty":14.455899,"median":37.997597,"eighty":61.934385,"marketCap":13601756631},{"date":"2024-04-05","current":11.30472,"twenty":14.395746,"median":37.829562,"eighty":61.889111,"marketCap":12828980310},{"date":"2024-04-12","current":11.434614,"twenty":14.190992,"median":37.744722,"eighty":61.843383,"marketCap":12976388510},{"date":"2024-04-19","current":10.978016,"twenty":14.097435,"median":37.720229,"eighty":61.737288,"marketCap":12458226353},{"date":"2024-04-26","current":11.170864,"twenty":13.930103,"median":37.622254,"eighty":61.590913,"marketCap":12677076753},{"date":"2024-05-03","current":11.429173,"twenty":13.857739,"median":37.494887,"eighty":61.301823,"marketCap":12970214422},{"date":"2024-05-10","current":15.790439,"twenty":13.745111,"median":37.220558,"eighty":61.104216,"marketCap":12613939409},{"date":"2024-05-17","current":15.739176,"twenty":13.753736,"median":37.112786,"eighty":60.998094,"marketCap":12573351116},{"date":"2024-05-24","current":15.157707,"twenty":13.808268,"median":34.822839,"eighty":60.858379,"marketCap":12108840655},{"date":"2024-05-31","current":14.898022,"twenty":13.852118,"median":32.773769,"eighty":60.755916,"marketCap":11901389381},{"date":"2024-06-07","current":15.331469,"twenty":13.879102,"median":32.556622,"eighty":60.617519,"marketCap":12247651204},{"date":"2024-06-14","current":15.393723,"twenty":13.894843,"median":32.486824,"eighty":60.463826,"marketCap":12297383268},{"date":"2024-06-21","current":15.071134,"twenty":13.897092,"median":32.455803,"eighty":60.288176,"marketCap":12039680751},{"date":"2024-06-28","current":15.093772,"twenty":13.904805,"median":32.339474,"eighty":60.258901,"marketCap":12057765138},{"date":"2024-07-05","current":14.669312,"twenty":13.920951,"median":32.246411,"eighty":60.178394,"marketCap":11718682879},{"date":"2024-07-12","current":15.127728,"twenty":13.960618,"median":31.928445,"eighty":60.006404,"marketCap":12084891719},{"date":"2024-07-15","current":15.150366,"twenty":13.981981,"median":31.796605,"eighty":59.980789,"marketCap":12102976106},{"date":"2024-08-02","current":16.123793,"twenty":14.003344,"median":31.734563,"eighty":59.955173,"marketCap":12880604754},{"date":"2024-08-09","current":17.406437,"twenty":14.059562,"median":31.277002,"eighty":59.651445,"marketCap":11718640189},{"date":"2024-08-16","current":18.245141,"twenty":14.081953,"median":31.218837,"eighty":59.351376,"marketCap":12283285949},{"date":"2024-08-23","current":18.458146,"twenty":14.097435,"median":31.168428,"eighty":59.252573,"marketCap":12426688047},{"date":"2024-08-30","current":19.390039,"twenty":14.125705,"median":31.141285,"eighty":59.09156,"marketCap":13054072226},{"date":"2024-09-06","current":19.350101,"twenty":14.146138,"median":31.063732,"eighty":58.974461,"marketCap":13027184332},{"date":"2024-09-13","current":18.338331,"twenty":14.160754,"median":31.005568,"eighty":58.937867,"marketCap":12346024367},{"date":"2024-09-20","current":18.631211,"twenty":14.184848,"median":30.990057,"eighty":58.879317,"marketCap":12543202252},{"date":"2024-09-27","current":18.764339,"twenty":14.243506,"median":30.904749,"eighty":58.641458,"marketCap":12632828563},{"date":"2024-10-04","current":18.471458,"twenty":14.326324,"median":30.775014,"eighty":58.287732,"marketCap":12435650679},{"date":"2024-10-11","current":18.298392,"twenty":14.368253,"median":30.610049,"eighty":58.012489,"marketCap":12319136474},{"date":"2024-10-18","current":18.67115,"twenty":14.390686,"median":30.54413,"eighty":57.699824,"marketCap":12570090145},{"date":"2024-10-25","current":18.158608,"twenty":14.408114,"median":30.465593,"eighty":57.566941,"marketCap":12225028847},{"date":"2024-10-31","current":18.098701,"twenty":14.411846,"median":30.382231,"eighty":57.528884,"marketCap":12184697007},{"date":"2024-11-08","current":10.289745,"twenty":14.406989,"median":30.354125,"eighty":57.466826,"marketCap":11782880049},{"date":"2024-11-15","current":9.925026,"twenty":14.223393,"median":30.330859,"eighty":57.444951,"marketCap":11365236488},{"date":"2024-11-22","current":10.243185,"twenty":14.10977,"median":30.171876,"eighty":57.378974,"marketCap":11729563850},{"date":"2024-11-29","current":10.344065,"twenty":14.04607,"median":30.088852,"eighty":57.232599,"marketCap":11845082282},{"date":"2024-12-06","current":10.239305,"twenty":13.894281,"median":29.997383,"eighty":57.230825,"marketCap":11725120833},{"date":"2024-12-13","current":9.781466,"twenty":13.745303,"median":29.892686,"eighty":57.217798,"marketCap":11200844873},{"date":"2024-12-20","current":9.420627,"twenty":13.663787,"median":29.795746,"eighty":57.141115,"marketCap":10787644329},{"date":"2024-12-27","current":9.855186,"twenty":13.579288,"median":29.601864,"eighty":57.126477,"marketCap":11285262189},{"date":"2025-01-03","current":10.006506,"twenty":13.531271,"median":29.389187,"eighty":57.100862,"marketCap":11458539837},{"date":"2025-01-10","current":10.165586,"twenty":13.458029,"median":29.384716,"eighty":57.078905,"marketCap":11640703518},{"date":"2025-01-17","current":12.008583,"twenty":13.264639,"median":29.284382,"eighty":57.05329,"marketCap":13751136407},{"date":"2025-01-24","current":11.880543,"twenty":13.173566,"median":29.224184,"eighty":57.011305,"marketCap":13604516859},{"date":"2025-01-31","current":12.256903,"twenty":13.053885,"median":29.19859,"eighty":56.923371,"marketCap":14035489470},{"date":"2025-02-07","current":12.183183,"twenty":12.930518,"median":29.127468,"eighty":56.889499,"marketCap":13951072155},{"date":"2025-02-14","current":16.37486,"twenty":12.913057,"median":29.097649,"eighty":56.873866,"marketCap":14065726416},{"date":"2025-02-21","current":16.813743,"twenty":12.927331,"median":28.991567,"eighty":56.853021,"marketCap":14442719083},{"date":"2025-02-28","current":16.833921,"twenty":12.943264,"median":28.872386,"eighty":56.839993,"marketCap":14460052079},{"date":"2025-03-07","current":16.788519,"twenty":12.984673,"median":28.666911,"eighty":56.830068,"marketCap":14421052838},{"date":"2025-03-14","current":16.485842,"twenty":13.031997,"median":28.143472,"eighty":56.813938,"marketCap":14161057895},{"date":"2025-03-21","current":16.899501,"twenty":13.049744,"median":27.981993,"eighty":56.738584,"marketCap":14516384317},{"date":"2025-03-28","current":15.966245,"twenty":13.070449,"median":27.828632,"eighty":56.720287,"marketCap":13714733243},{"date":"2025-04-04","current":16.03687,"twenty":13.112851,"median":27.609843,"eighty":56.720287,"marketCap":13775398729},{"date":"2025-04-11","current":15.744282,"twenty":13.135338,"median":27.489212,"eighty":56.683693,"marketCap":13524070285},{"date":"2025-04-17","current":16.238655,"twenty":13.157825,"median":27.373688,"eighty":56.63978,"marketCap":13948728691},{"date":"2025-04-25","current":16.157941,"twenty":13.203924,"median":27.227853,"eighty":56.610156,"marketCap":13879396707},{"date":"2025-05-02","current":16.384949,"twenty":13.220789,"median":27.175409,"eighty":56.605494,"marketCap":14074392914},{"date":"2025-05-09","current":13.13487,"twenty":13.220789,"median":27.160092,"eighty":56.580228,"marketCap":14343054355},{"date":"2025-05-16","current":12.773553,"twenty":13.130466,"median":27.076244,"eighty":56.544637,"marketCap":13955796159},{"date":"2025-05-23","current":12.461156,"twenty":13.066308,"median":26.904805,"eighty":56.28848,"marketCap":13614485927},{"date":"2025-05-30","current":12.588429,"twenty":12.968109,"median":26.873672,"eighty":56.212937,"marketCap":13753538244},{"date":"2025-06-06","current":13.016528,"twenty":12.90448,"median":26.797021,"eighty":56.195426,"marketCap":14221259673},{"date":"2025-06-13","current":13.602754,"twenty":12.90448,"median":26.668197,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-06-20","current":13.463911,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14710049635},{"date":"2025-06-27","current":13.602754,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-07-03","current":14.026996,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15325250795},{"date":"2025-07-11","current":13.930577,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15219908130},{"date":"2025-07-18","current":13.679889,"twenty":12.997415,"median":26.697563,"eighty":56.189678,"marketCap":14946017203},{"date":"2025-07-25","current":14.111845,"twenty":13.115975,"median":26.697563,"eighty":56.189678,"marketCap":15417952339},{"date":"2025-08-01","current":14.192836,"twenty":13.181814,"median":26.697563,"eighty":56.189678,"marketCap":15506440177},{"date":"2025-08-08","current":15.6743,"twenty":13.310592,"median":26.697563,"eighty":56.189678,"marketCap":15999165780},{"date":"2025-08-15","current":15.458307,"twenty":13.437714,"median":26.697563,"eighty":56.189678,"marketCap":15778696325},{"date":"2025-08-22","current":15.37784,"twenty":13.501317,"median":26.697563,"eighty":56.189678,"marketCap":15696560645},{"date":"2025-08-29","current":15.085614,"twenty":13.602754,"median":26.697563,"eighty":56.189678,"marketCap":15398278441},{"date":"2025-09-05","current":15.627714,"twenty":13.682974,"median":26.726929,"eighty":56.189678,"marketCap":15951613545},{"date":"2025-09-12","current":15.54301,"twenty":13.727713,"median":26.697563,"eighty":56.189678,"marketCap":15865154935},{"date":"2025-09-19","current":15.132201,"twenty":13.827216,"median":26.697563,"eighty":56.189678,"marketCap":15445830676},{"date":"2025-09-26","current":14.780683,"twenty":13.857345,"median":26.697563,"eighty":56.189678,"marketCap":15087027445},{"date":"2025-10-03","current":15.454072,"twenty":13.907401,"median":26.697563,"eighty":56.189678,"marketCap":15774373394},{"date":"2025-10-10","current":15.305842,"twenty":13.996913,"median":26.697563,"eighty":56.189678,"marketCap":15623070827},{"date":"2025-10-17","current":15.390545,"twenty":14.093333,"median":26.697563,"eighty":56.189678,"marketCap":15709529437},{"date":"2025-10-24","current":15.606538,"twenty":14.18067,"median":26.697563,"eighty":56.189678,"marketCap":15929998892},{"date":"2025-10-31","current":15.644654,"twenty":14.376689,"median":26.697563,"eighty":56.189678,"marketCap":15968905267},{"date":"2025-11-07","current":22.776673,"twenty":14.487757,"median":26.697563,"eighty":56.189678,"marketCap":17423152601},{"date":"2025-11-14","current":22.190221,"twenty":14.585763,"median":26.697563,"eighty":56.189678,"marketCap":16974542737},{"date":"2025-11-21","current":21.441797,"twenty":14.71386,"median":26.697563,"eighty":56.189678,"marketCap":16402031102},{"date":"2025-11-28","current":22.352193,"twenty":14.852999,"median":26.697563,"eighty":56.189678,"marketCap":17098444509},{"date":"2025-12-05","current":21.866276,"twenty":14.925958,"median":26.697563,"eighty":56.189678,"marketCap":16726739194},{"date":"2025-12-12","current":21.676378,"twenty":15.032381,"median":26.697563,"eighty":56.189678,"marketCap":16581475048},{"date":"2025-12-19","current":21.464138,"twenty":15.093897,"median":26.697563,"eighty":56.189678,"marketCap":16419121002},{"date":"2025-12-26","current":21.922129,"twenty":15.149631,"median":26.697563,"eighty":56.189678,"marketCap":16769463943},{"date":"2026-01-02","current":21.581428,"twenty":15.187258,"median":26.697563,"eighty":56.189678,"marketCap":16508842974},{"date":"2026-01-09","current":22.48624,"twenty":15.23808,"median":26.697563,"eighty":56.189678,"marketCap":17200983907},{"date":"2026-01-16","current":22.184636,"twenty":15.252479,"median":26.697563,"eighty":56.189678,"marketCap":16970270263},{"date":"2026-01-23","current":22.402461,"twenty":15.277931,"median":26.697563,"eighty":56.189678,"marketCap":17136896783},{"date":"2026-01-30","current":22.821355,"twenty":15.310924,"median":26.697563,"eighty":56.189678,"marketCap":17457332400},{"date":"2026-02-06","current":24.630978,"twenty":15.328798,"median":26.697563,"eighty":56.189678,"marketCap":18841614264},{"date":"2026-02-13","current":24.895555,"twenty":15.360052,"median":26.697563,"eighty":56.189678,"marketCap":19193153817},{"date":"2026-02-20","current":25.067824,"twenty":15.379534,"median":26.630837,"eighty":56.189678,"marketCap":19325963587},{"date":"2026-02-27","current":25.20675,"twenty":15.379534,"median":26.529015,"eighty":56.189678,"marketCap":19433068240},{"date":"2026-03-06","current":25.384575,"twenty":15.379534,"median":26.382064,"eighty":56.189678,"marketCap":19570162196},{"date":"2026-03-13","current":25.490159,"twenty":15.379534,"median":26.335729,"eighty":56.189678,"marketCap":19651561732},{"date":"2026-03-20","current":25.30122,"twenty":15.379534,"median":26.159501,"eighty":56.189678,"marketCap":19505899404},{"date":"2026-03-27","current":26.084763,"twenty":15.379534,"median":26.077607,"eighty":56.189678,"marketCap":20109969647}],"updateTime":1774742942564},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RPRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603655981","title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603655981","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603655981?lang=en_us&edition=fundamental","pubTime":"2026-01-14 06:38","pubTimestamp":1768343903,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments at Royalty Pharma plc, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL4MDx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602517360","title":"Royalty Pharma provides update on business performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517360?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:36","pubTimestamp":1768221382,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) provided an update on its business performance, including recent key accomplishments. Key highlights include: Royalty funding...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/royalty-pharma-provides-update-on-business-performance-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/royalty-pharma-provides-update-on-business-performance-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602355512","title":"Royalty Pharma Targets 14%-16% Top-Line Growth for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2602355512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602355512?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:15","pubTimestamp":1768220113,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc announced that it is on track to deliver its full-year guidance for 14%-16% top-line growth, as discussed during its third quarter 2025 earnings call. The company highlighted a landmark year in 2025, with $4.7 billion in royalty transactions and the royalty market reaching $10 billion for the first time. Royalty Pharma also noted that it has maintained its track record of double-digit growth during this period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLb3httq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","IE00BGHQF748.EUR","BK4588","LU0314104364.USD","RPRX","BK4007","BK4112","LU2095319765.USD","IE00BKPKM429.USD","NDAQ","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2602123615","title":"Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44TH Annual J.p. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602123615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602123615?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:15","pubTimestamp":1768220100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA7CJHTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602635685","title":"Royalty Pharma, Teva enter agreement to accelerate development of TEV-‘408","url":"https://stock-news.laohu8.com/highlight/detail?id=2602635685","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602635685?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:20","pubTimestamp":1768170007,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), announced a funding agreement of up to $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/royalty-pharma-teva-enter-agreement-to-accelerate-development-of-tev-408-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/royalty-pharma-teva-enter-agreement-to-accelerate-development-of-tev-408-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4559","BK4566","BK4584","BK4585","BK4588","BK4596","TEVA","RPRX","LU1983299246.USD","BK4557"],"gpt_icon":0},{"id":"2602568024","title":"BRIEF-Teva And Royalty Pharma Enter Agreement To Accelerate Development Of Potential Treatment For Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568024","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568024?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:16","pubTimestamp":1768169770,"startTime":"0","endTime":"0","summary":"BRIEF-Teva And Royalty Pharma Enter Agreement To Accelerate Development Of Potential Treatment For VitiligoJan 11 (Reuters) - Royalty Pharma PLC RPRX.O:TEVA AND ROYALTY PHARMA ENTER AGREEMENT TO ACCEL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602856872","title":"Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602856872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602856872?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602568723","title":"Teva - Teva to Share Tev-'408 Trial Results in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568723?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602568722","title":"Royalty Pharma  - to Provide up to $500 Mln for Teva's Tev-'408","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568722?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602456872","title":"Royalty Pharma : Tev-'408 Is Currently in Phase 1B for Treatment of Vitiligo and in Phase 2a for Celiac Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2602456872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602456872?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602568227","title":"Teva and Royalty Pharma Partner in $500 Million Deal to Advance TEV-'408 for Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568227","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568227?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:00","pubTimestamp":1768168824,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries Ltd. has entered into a funding agreement with Royalty Pharma plc to accelerate the clinical development of Teva's anti-IL-15 antibody, TEV-'408, for the treatment of vitiligo and other autoimmune diseases. Under the terms of the agreement, Royalty Pharma will provide up to $500 million to support ongoing research and development, including $75 million to fund a Phase 2b study starting in 2026. Pending positive results from this study, Royalty Pharma has the option to invest an additional $425 million to support Phase 3 development. If TEV-'408 is approved and launched, Teva will pay Royalty Pharma a milestone payment and royalties on global net sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva P","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nNDL4rM5QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4007","IE00B3QW5Z07.USD","BK4588","BK4112","RPRX","SG9999014021.USD","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014039.USD","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","LU2095319765.USD"],"gpt_icon":0},{"id":"2602587557","title":"Assessing Royalty Pharma (RPRX) Valuation After Dividend Increase And Raised Full Year Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602587557","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602587557?lang=en_us&edition=fundamental","pubTime":"2026-01-10 18:23","pubTimestamp":1768040608,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) has drawn fresh attention after its board approved a 6.8% increase in the quarterly dividend to US$0.235 per Class A share, along with raised full year guidance following recent results.\nSee our latest analysis for Royalty Pharma.\nThe dividend increase and higher full year guidance come after a period of improving momentum, with the share price at US$40.17, a 90 day share price return of 11.55% and a 1 year total shareholder return of 39.65%, suggesting sentiment has...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/assessing-royalty-pharma-rprx-valuation-after-dividend-incre","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/assessing-royalty-pharma-rprx-valuation-after-dividend-incre","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602137916","title":"Royalty Pharma Increases Quarterly Dividend to $0.235 a Share From $0.22, Payable March 10 to Holders of Record on Feb. 20.","url":"https://stock-news.laohu8.com/highlight/detail?id=2602137916","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602137916?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:45","pubTimestamp":1767966303,"startTime":"0","endTime":"0","summary":"Royalty Pharma Increases Quarterly Dividend to $0.235 a Share From $0.22, Payable March 10 to Holders of Record on Feb. 20.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602376021","title":"Royalty Pharma announces $0.235 quarterly dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376021","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376021?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:30","pubTimestamp":1767965423,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc has announced a first quarter 2026 dividend of $0.235 per Class A ordinary share, representing a 6.8% increase over the previous quarter's dividend.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL1w0H5D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","RPRX","SG9999014013.SGD","LU0314104364.USD","BK4007","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD","BK4112","LU2210150020.SGD","SG9999014039.USD","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","NDAQ"],"gpt_icon":0},{"id":"2602365379","title":"Royalty Pharma : Dividend of $0.235 per Share Reflects 6.8% Increase in Company's Quarterly Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2602365379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602365379?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:30","pubTimestamp":1767965400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nTUA8HX4GQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602057376","title":"Royalty Pharma  - Declares Dividend of $0.235 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2602057376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602057376?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:30","pubTimestamp":1767965400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nTUA8HX4GQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2601502843","title":"Royalty Pharma Files Initial Beneficial Ownership Statement for Arthur Richard McGivern, EVP, Investments & General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2601502843","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601502843?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:21","pubTimestamp":1767734466,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing names Arthur Richard McGivern as the beneficial owner, who serves as Executive Vice President, Investments & General Counsel at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL10RX68:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Royalty Pharma Files Initial Beneficial Ownership Statement for Arthur Richard McGivern, EVP, Investments & General Counsel","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2601843378","title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601843378","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601843378?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:18","pubTimestamp":1767734314,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments at Royalty Pharma plc, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDLbbZ7cd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2601897193","title":"Denali Therapeutics reports $872.9 million cash position ahead of key 2026 milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897193","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601897193?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:03","pubTimestamp":1767704617,"startTime":"0","endTime":"0","summary":"Denali Therapeutics Inc. reported that as of September 30, 2025, it held approximately $872.9 million in cash, cash equivalents, and marketable securities. In December 2025, the company raised around $200 million through an equity financing and announced a royalty funding agreement with Royalty Pharma, which could provide proceeds of up to $275 million based on future net sales of tividenofusp alfa. These developments indicate a significant strengthening of Denali’s financial position as it prepares for key milestones in 2026, including the potential US accelerated approval and launch of tividenofusp alfa.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Denali Therapeutics Inc. published the original content used to generate this news b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDLB0dpW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","RPRX","BK4007","BK4548","DNLI"],"gpt_icon":0},{"id":"2600559708","title":"What's Going On With Royalty Pharma Stock Wednesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2600559708","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600559708?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:47","pubTimestamp":1767196020,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc  stock has gained around 53% year to date, as per data from Benzinga Pro.On Monday, Royalty Pharma acquired the final portion of PTC Therapeutics Inc.’s  remaining royalty on Roche Holdings AG’s  Evrysdi for $240 million upfront and up to $60 million in sales-based milestones.Evrysdi, marketed by Roche, is an orally administered survival motor neuron-2  splicing modifier for the treatment of spinal muscular atrophy .Also Read: Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start. The FDA approved Evrysdi in 2020 and has treated over 21,000 patients worldwide.In 2024, Evrysdi generated sales of approximately 1.6 billion Swiss francs , representing 18% year-over-year growth at constant exchange rates, and is projected to reach 2.3 billion Swiss francs  of sales by 2030 based on analyst consensus.In March 2025, Novartis AG  shared safety and efficacy results from the Phase 3 program for investigational intrathecal onasemnogene abeparvovec  in a broad popu","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/31/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/31/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49649858/whats-going-on-with-royalty-pharma-stock-wednesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49649858/whats-going-on-with-royalty-pharma-stock-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["IE0009355771.USD","IE00B19Z9Z06.USD","SMA","IE00B894F039.SGD","LU0109394709.USD","RPRX","IE00BJJMRZ35.SGD","BK4533","LU0211331839.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE0002141913.USD","LU0320765992.SGD","BK4578","BK4588","BK4139","BIIB","IE00BJT1NW94.SGD","LU0208291251.USD","NVS","BK4585","NUVL","IE00B2B36J28.USD","BK4539","PTCT","LU0070302665.USD","LU0320765489.SGD","LU0234570918.USD","IE00B19Z9P08.USD","BK4532","BK4217","IE00BFTCPJ56.SGD","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":97,"code":"91000000","status":"200"}]}}